164 related articles for article (PubMed ID: 8252208)
21. Accumulation of benzoporphyrin derivative in malignant and host cell populations of the murine RIF tumor.
Korbelik M; Krosl G
Cancer Lett; 1995 Nov; 97(2):249-54. PubMed ID: 7497470
[TBL] [Abstract][Full Text] [Related]
22. The use of photodynamic therapy in bone marrow purging.
Mulroney CM; Glück S; Ho AD
Semin Oncol; 1994 Dec; 21(6 Suppl 15):24-7. PubMed ID: 7992104
[TBL] [Abstract][Full Text] [Related]
23. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
Schaffer M; Schaffer PM; Corti L; Gardiman M; Sotti G; Hofstetter A; Jori G; Dühmke E
J Photochem Photobiol B; 2002 Apr; 66(3):157-64. PubMed ID: 11960724
[TBL] [Abstract][Full Text] [Related]
24. Comparative skin phototoxicity in mice with two photosensitizing drugs: benzoporphyrin derivative monoacid ring A and porfimer sodium (Photofrin).
Wolford ST; Novicki DL; Kelly B
Fundam Appl Toxicol; 1995 Jan; 24(1):52-6. PubMed ID: 7713343
[TBL] [Abstract][Full Text] [Related]
25. Cellular distribution and phototoxicity of benzoporphyrin derivative and Photofrin.
Rousset N; Vonarx V; Eléouet S; Carré J; Bourré L; Lajat Y; Patrice T
Res Exp Med (Berl); 2000 Jun; 199(6):341-57. PubMed ID: 10945652
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic treatment of oral squamous cell carcinoma in hamster cheek pouch model using chlorin p6-histamine conjugate.
Parihar A; Dube A; Gupta PK
Photodiagnosis Photodyn Ther; 2013 Feb; 10(1):79-86. PubMed ID: 23465376
[TBL] [Abstract][Full Text] [Related]
27. Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model.
Borle F; Radu A; Fontolliet C; van den Bergh H; Monnier P; Wagnières G
Br J Cancer; 2003 Dec; 89(12):2320-6. PubMed ID: 14676813
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis.
Trauner KB; Gandour-Edwards R; Bamberg M; Shortkroff S; Sledge C; Hasan T
Photochem Photobiol; 1998 Jan; 67(1):133-9. PubMed ID: 9477771
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
30. Novel delivery of Chlorin e6 using anti-EGFR antibody tagged virosomes for fluorescence diagnosis of oral cancer in a hamster cheek pouch model.
Low KP; Bhuvaneswari R; Thong PS; Bunte RM; Soo KC
Eur J Pharm Sci; 2016 Feb; 83():143-54. PubMed ID: 26709081
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Reuther T; Kübler AC; Zillmann U; Flechtenmacher C; Sinn H
Lasers Surg Med; 2001; 29(4):314-22. PubMed ID: 11746108
[TBL] [Abstract][Full Text] [Related]
32. Vascular effects of photodynamic and pulsed dye laser therapy protocols.
Channual J; Choi B; Osann K; Pattanachinda D; Lotfi J; Kelly KM
Lasers Surg Med; 2008 Nov; 40(9):644-50. PubMed ID: 18951421
[TBL] [Abstract][Full Text] [Related]
33. The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy?
Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Jori G; Dühmke E; Hofstetter A
Curr Med Chem; 2005; 12(10):1209-15. PubMed ID: 15892632
[TBL] [Abstract][Full Text] [Related]
34. A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer.
Mir Y; Elrington SA; Hasan T
Nanomedicine; 2013 Oct; 9(7):1114-22. PubMed ID: 23485748
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin.
Schmidt-Erfurth U; Bauman W; Gragoudas E; Flotte TJ; Michaud NA; Birngruber R; Hasan T
Ophthalmology; 1994 Jan; 101(1):89-99. PubMed ID: 8302569
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy of choriocarcinoma transplanted to the hamster cheek pouch. I. Intraperitoneal photosensitization.
Brand E; Choi HS; Karalis K; Papaioannou T; Fishbein MC; Braunstein G; Wade ME; Lagasse LD; Grundfest WS
Gynecol Oncol; 1990 Feb; 36(2):200-6. PubMed ID: 2137105
[TBL] [Abstract][Full Text] [Related]
37. Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors.
Schmidt-Erfurth U; Flotte TJ; Gragoudas ES; Schomacker K; Birngruber R; Hasan T
Exp Eye Res; 1996 Jan; 62(1):1-10. PubMed ID: 8674504
[TBL] [Abstract][Full Text] [Related]
38. Mono- and tri-cationic porphyrin-monoclonal antibody conjugates: photodynamic activity and mechanism of action.
Smith K; Malatesti N; Cauchon N; Hunting D; Lecomte R; van Lier JE; Greenman J; Boyle RW
Immunology; 2011 Feb; 132(2):256-65. PubMed ID: 21039468
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcome of Photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia.
Ikeda H; Tobita T; Ohba S; Uehara M; Asahina I
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):229-35. PubMed ID: 23993848
[TBL] [Abstract][Full Text] [Related]
40. Mode of action of photodynamic therapy with sulfonated aluminum phthalocyanine in induced squamous cell carcinomas in animal models.
von Glass W; Kásler M; Lang T
Eur Arch Otorhinolaryngol; 1992; 249(6):309-12. PubMed ID: 1418939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
